Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Church currently holds 300,000 shares of Athira Pharma, Inc. (ATHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Church has been a net seller of ATHA stock. They have purchased $0 and sold $38.3K worth of shares.
Kevin Church's most recent insider trade was on Apr 9, 2026, when they sold 300,000 shares at $0.00 per share.
Kevin Church serves as Executive at Athira Pharma, Inc. (ATHA). They have executed 38 insider transactions totaling $38.3K over their tenure at the company.
Kevin Church holds the position of Executive at Athira Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Kevin Church has shown a selling trading pattern, with $0 in total purchases and $38.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin Church was on Mar 24, 2023, when they sold $8.7K worth of ATHA shares. This transaction involved 6,410 shares at $1.35 per share.
Kevin Church currently owns 300,000 shares of Athira Pharma, Inc. (ATHA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Church's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Church has 38 Form 4 filings on record as an insider at Athira Pharma, Inc..
Set alerts for Kevin Church and 40,000+ other insiders.